Perspectives in Clinical Research

CLINICAL RESEARCH METHODOLOGY
Year
: 2010  |  Volume : 1  |  Issue : 3  |  Page : 104--105

Outcomes research and drug development


Sandeep Duttagupta 
 Head, Market Access & Pricing Emerging Markets Business Unit Pfizer Inc

Correspondence Address:
Sandeep Duttagupta
Head, Market Access & Pricing Emerging Markets Business Unit Pfizer Inc

With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovative drugs. A multi-disciplinary approach towards drug development is important in order to demonstrate the value of innovation to physicians and patients. Input into the drug development process at various stages of clinical trials must incorporate patient-focused endpoints and analyses. Demonstrating value of drugs will help ensure that innovative therapies should be seen as health care investment and not expense.


How to cite this article:
Duttagupta S. Outcomes research and drug development.Perspect Clin Res 2010;1:104-105


How to cite this URL:
Duttagupta S. Outcomes research and drug development. Perspect Clin Res [serial online] 2010 [cited 2020 Oct 30 ];1:104-105
Available from: https://www.picronline.org/article.asp?issn=2229-3485;year=2010;volume=1;issue=3;spage=104;epage=105;aulast=Duttagupta;type=0